Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Deisenhammer

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
CNS Drugs|May 21, 2009
Neutralizing antibodies to interferon-beta and other immunological treatments for multiple sclerosis: prevalence and impact on outcomesFlorian Deisenhammer
Neurology|February 20, 2013
Multiple sclerosis or multiple possibilities: the continuing problem of misdiagnosisFlorian Deisenhammer
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 11, 2014
Interferon-Beta: Neutralizing Antibodies, Binding Antibodies, Pharmacokinetics and Pharmacodynamics, and Clinical OutcomesFlorian Deisenhammer
Multiple Sclerosis and Related Disorders|April 21, 2015
Socio-economic aspects of the testing for antibodies in MS-patients under interferon therapy in Austria: a cost of illness studyEvelyn Walter, Florian Deisenhammer
The New England Journal of Medicine|October 21, 2005
Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosisThomas Berger, Florian Deisenhammer
Ebiomedicine|February 1, 2026
Letter in response to "Kappa free light chain index as a substitute to oligoclonal bands in diagnosing multiple sclerosis"Florian Deisenhammer, Harald Hegen
Neurology|September 5, 2012
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trialFlorian Deisenhammer, Harald Hegen
Lancet (London, England)|January 17, 2004
Neutralising antibodies against interferon beta in multiple sclerosisGavin Giovannoni, Florian Deisenhammer
Handbook of Clinical Neurology|November 8, 2017
Psychiatric syndromes other than dementiaKarl Bechter, Florian Deisenhammer
Clinical Chemistry and Laboratory Medicine|December 5, 2009
Stability of cerebrospinal fluid/serum glucose ratio and cerebrospinal fluid lactate concentrations over 24 h: analysis of repeated measurementsIrena Dujmovic, Florian Deisenhammer
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
CNS Drugs|May 21, 2009
Neutralizing antibodies to interferon-beta and other immunological treatments for multiple sclerosis: prevalence and impact on outcomesFlorian Deisenhammer
Neurology|February 20, 2013
Multiple sclerosis or multiple possibilities: the continuing problem of misdiagnosisFlorian Deisenhammer
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 11, 2014
Interferon-Beta: Neutralizing Antibodies, Binding Antibodies, Pharmacokinetics and Pharmacodynamics, and Clinical OutcomesFlorian Deisenhammer
Multiple Sclerosis and Related Disorders|April 21, 2015
Socio-economic aspects of the testing for antibodies in MS-patients under interferon therapy in Austria: a cost of illness studyEvelyn Walter, Florian Deisenhammer
The New England Journal of Medicine|October 21, 2005
Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosisThomas Berger, Florian Deisenhammer
Ebiomedicine|February 1, 2026
Letter in response to "Kappa free light chain index as a substitute to oligoclonal bands in diagnosing multiple sclerosis"Florian Deisenhammer, Harald Hegen
Neurology|September 5, 2012
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trialFlorian Deisenhammer, Harald Hegen
Lancet (London, England)|January 17, 2004
Neutralising antibodies against interferon beta in multiple sclerosisGavin Giovannoni, Florian Deisenhammer
Handbook of Clinical Neurology|November 8, 2017
Psychiatric syndromes other than dementiaKarl Bechter, Florian Deisenhammer
Clinical Chemistry and Laboratory Medicine|December 5, 2009
Stability of cerebrospinal fluid/serum glucose ratio and cerebrospinal fluid lactate concentrations over 24 h: analysis of repeated measurementsIrena Dujmovic, Florian Deisenhammer
Pageof 23